← SynDRA

METHYLPREDNISOLONE HEMISUCCINATE

SynDRA canonical compound SYN0023504 — structure-anchored drug synonym record

Clinical phaseLaunched
Approval statusApproved · Rx/OTC
Mechanism of actionglucocorticoid receptor agonist
Indicationhypercalcemia, thyroiditis, osteoarthritis, rheumatoid arthritis, seborrheic dermatitis, asthma, allergic rhinitis, shingles, conjunctivitis, ulcerative colitis, enteritis, anemia, multiple sclerosis, mycosis
Disease areaendocrinology, rheumatology, dermatology, pulmonary, allergy, infectious disease, ophthalmology, gastroenterology, hematology, neurology/psychiatry

All known targets

Mechanisms of action (all sources)

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)

Drug classes

ATC classes

Cross-references

Synonyms

Reported adverse events

Look up METHYLPREDNISOLONE HEMISUCCINATE in the interactive SynDRA portal →